Tandem Diabetes Care (TNDM) EBT (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported EBT for 14 consecutive years, with -$20.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 64.14% year-over-year to -$20.7 million; the trailing twelve-month figure through Jun 2026 stood at -$61.0 million (up 69.86% YoY), and the FY2025 full-year result was -$200.3 million, down 117.99% from the prior year.
• EBT eased to -$20.7 million in Q2 2026 per TNDM's latest filing, from -$19.9 million in the prior quarter.
• Across five years, EBT topped out at $4.7 million in Q4 2025 and bottomed at -$123.6 million in Q1 2023.
• Historically, EBT has averaged -$35.9 million across 5 years, with a median of -$27.4 million in 2024.
• The sharpest annual moves came in 2022 and 2025: EBT sank 909.66% in 2022, then surged 15660.0% in 2025.
• Over 5 years, EBT stood at -$16.1 million in 2022, then tumbled by 94.3% to -$31.3 million in 2023, then soared by 100.1% to $30000.0 in 2024, then soared by 15660.0% to $4.7 million in 2025, then slumped by 537.82% to -$20.7 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$20.7 million, -$19.9 million, and $4.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.